Knoll Capital Management, LLC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 94 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.

Quarter-by-quarter ownership
Knoll Capital Management, LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$586,000
-86.6%
585,966
-15.6%
0.34%
-86.3%
Q2 2022$4,374,000
-24.1%
694,2320.0%2.50%
-30.9%
Q1 2022$5,762,000
+59.9%
694,2320.0%3.62%
+82.6%
Q4 2021$3,603,000
-22.3%
694,2320.0%1.98%
-14.4%
Q3 2021$4,637,000
-21.6%
694,2320.0%2.31%
-25.2%
Q2 2021$5,915,000
-3.7%
694,2320.0%3.09%
-22.8%
Q1 2021$6,144,000
-28.0%
694,2320.0%4.00%
-31.2%
Q4 2020$8,532,000
+76.1%
694,232
+16.6%
5.82%
+46.5%
Q3 2020$4,845,000
-4.3%
595,238
+13.3%
3.97%
+35.8%
Q2 2020$5,063,000
+56.7%
525,238
+10.5%
2.92%
-3.7%
Q1 2020$3,232,000
-38.1%
475,238
+35.7%
3.04%
-21.2%
Q4 2019$5,219,000
+45.4%
350,2380.0%3.85%
+17.3%
Q3 2019$3,590,000
-3.3%
350,2380.0%3.29%
+8.1%
Q2 2019$3,713,000
+252.9%
350,238
+365.5%
3.04%
+280.5%
Q1 2019$1,052,000
+37.7%
75,2380.0%0.80%
-8.1%
Q4 2018$764,000
-16.0%
75,2380.0%0.87%
+13.0%
Q3 2018$910,000
-0.9%
75,2380.0%0.77%
-1.4%
Q2 2018$918,000
+23.9%
75,2380.0%0.78%
+2.5%
Q1 2018$741,00075,2380.76%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Vivo Capital, LLC 1,787,091$14,118,0003.56%
INTERWEST VENTURE MANAGEMENT CO 1,599,592$12,637,0002.99%
SPHERA FUNDS MANAGEMENT LTD. 385,301$3,044,0000.52%
Boxer Capital, LLC 138,331$1,093,0000.26%
DAFNA Capital Management LLC 35,977$284,0000.20%
SABBY MANAGEMENT, LLC 223,100$1,762,0000.12%
Hikari Power Ltd 60,992$482,0000.06%
Perceptive Advisors 157,679$1,245,0000.06%
Lombard Odier Asset Management (USA) Corp 90,000$711,0000.06%
TFS CAPITAL LLC 12,128$96,0000.04%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders